Expression of mTOR and downstream signalling components in the JEG-3 and BeWo human placental choriocarcinoma cell lines

International Journal of Molecular Medicine

Volumn 25, Issue 1, 2010, Pages 65-69

  Mparmpakas, Dionisis ^a   Zachariades, Elena ^a   Foster, Helen ^a   Kara, Anjeli ^a   Harvey, Amanda ^a   Goumenou, Anastasia ^a,b   Karteris, Emmanouil ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

EIF4E binding proteins; mTOR; Placenta; S6 Kinase; Syncytialisation

Indexed keywords

FORSKOLIN; INITIATION FACTOR 4E; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; S6 KINASE; SERINE; THREONINE;

ARTICLE; CANCER CELL CULTURE; CELL STIMULATION; CHORIOCARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; CHORIOCARCINOMA; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; FORSKOLIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHORYLATION; PLACENTA; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; RIBOSOMAL PROTEIN S6 KINASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; UTERINE NEOPLASMS;

EID: 70549108871     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000314     Document Type: Article

References (23)

1. Hay N and Sonenberg N: Upstream and downstream of mTOR. Genes Dev 18: 1926-1945, 2004.
2. Petroulakis E, Mamane Y, Le Bacquer O, Shahbazian D and Sonenberg N: mTOR signaling: implications for cancer and anticancer therapy. Br J Cancer 94: 195-199, 2006.
3. Asnaghi L, Bruno P, Priulla M and Nicolin A: mTOR: a protein kinase switching between life and death. Pharmacol Res 50: 545-549, 2004.
4. Dufner A and Thomas G: Ribosomal S6 kinase signalling and the control of transaltion. Exp Cell Res 253: 100-109, 1999.
5. Panasyuk G, Nemazanyy I, Zhyvoloup A, et al: Nuclear export of S6K1 II is regulated by protein kinase CK2 phosphorylation at Ser-17. J Biol Chem 281: 31188-31201, 2006.
6. Valovka T, Verdier F, Cramer R, et al: Protein kinase C phosphorylates ribosomal protein S6 kinase betaII and regulates its subcellular localization. Mol Cell Biol 23: 852-863, 2003.
7. Gangloff YG, Mueller M, Dann SG, et al: Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol 24: 9508-9516, 2004.
8. Roos S, Jansson N, Palmberg I, Säljö K, Powell TL and Jansson T: Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth. J Physiol 582: 449-459, 2007.
9. Wen HY, Abbasi S, Kellems RE and Xia Y: mTOR: A placental growth signaling sensor. Placenta 26: S63-S69, 2005.
10. Lim SS, Noakes M and Norman RJ: Dietary effects on fertility treatment and pregnancy outcomes. Curr Opin Endo Diabetes Obes 14: 465-469, 2007.
11. Bursztyn M and Ariel I: Maternal-Fetal deprivation and the cardiometabolic syndrome. J Cardiometab Syndr 1: 141-145, 2006.
12. Fulop V, Mok SC and Berkowitz RS: Molecular biology of gestational trophoblastic neoplasia: a review. J Reprod Med 49: 415-422, 2004.
13. Cheung AN: Pathology of gestational trophoblastc diseases. Best Pract Res Clin Obstet Gynaecol 7: 849-868, 2003.
14. Liu Y, Hidayat S, Su WH, Deng X, Yu DH and Yu BZ: Expression and activity of mTOR and its substrates in different cell cycle phases and in oral squamous cell carcinomas of different malignant grade. Cell Biochem Funct 25: 45-53, 2007.
15. Karteris E, Grammatopoulos D, Randeva H and Hillhouse EW: Signal transduction characteristics of the corticotropin-releasing hormone receptors in the feto-placental unit. J Clin Endocrinol Metab 85: 1989-1996, 2000.
16. Ntrivalas E, Kwak-Kim J, Beaman K, Mantouvalos H and Gilman-Sachs A: An in vitro coculture model to study cytokine profiles of natural killer cells during maternal immune cell-trophoblast interactions. J Soc Gynecol Investig 13: 196-202, 2006.
17. Das M, Xu B, Lin L, Chakrabarti S, Shivaswamy V and Rote NS: Phosphatidylserine efflux and intercellular fusion in a BeWo model of human villous cytotrophoblast. Placenta 25: 396-407, 2004.
18. Neelima PS and Rao AJ: Gene expression profiling during Forskolin induced differentiation of BeWo cells by diferential display RT-PCR. Mol Cell Endocrinol 281: 37-46, 2008.
19. Ellinger I, Schwab M, Stefanescu A, Hunziker W and Fuchs R: IgG transport across trophoblast-derived BeWo cells: a model system to study IgG transport in the placenta. Eur J Immunol 29: 733-744, 1999.
20. Heaton SJ, Eady JJ, Parker ML, et al: The use of BeWo cells as an in vitro model for placental iron transport. Am J Physiol Cell Physiol 295: 1445-1453, 2008.
21. Manley SW, Li H and Mortimer RH: The BeWo choriocarcinoma cell line as a model of iodide transport by placenta. Placenta 26: 380-386, 2005.
22. Bachmann RA, Kim JH, Wu AL, Park IH and Chen J: A nuclear transport signal in mammalian target of rapamycin is critical for its cytoplasmic signaling to S6 kinase 1. J Biol Chem 281: 7357-7363, 2006
23. Burleigh DW, Kendziorski CM, Choi YJ, Grindle KM, Grendell RL, Magness RR and Golos TG: Microarray analysis of BeWo and JEG3 trophoblast cell lines: identification of differentially expressed transcripts. Placenta. 28: 383-389, 2007.